142 related articles for article (PubMed ID: 31755808)
1. Synergistic Actions of Benzyl Isothiocyanate with Ethylenediaminetetraacetic Acid and Efflux Pump Inhibitor Phenylalanine-Arginine β-Naphthylamide Against Multidrug-Resistant
Lin KH; Lo CC; Chou MC; Yeh TH; Chen KL; Liao WY; Lo HR
Microb Drug Resist; 2020 May; 26(5):468-474. PubMed ID: 31755808
[TBL] [Abstract][Full Text] [Related]
2. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL
Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activities of an efflux pump inhibitor and iron chelators against Pseudomonas aeruginosa growth and biofilm formation.
Liu Y; Yang L; Molin S
Antimicrob Agents Chemother; 2010 Sep; 54(9):3960-3. PubMed ID: 20566773
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of eugenol with Colistin against clinical isolated Colistin-resistant
Wang YM; Kong LC; Liu J; Ma HX
Antimicrob Resist Infect Control; 2018; 7():17. PubMed ID: 29423192
[TBL] [Abstract][Full Text] [Related]
6. Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli.
Bag A; Chattopadhyay RR
Nat Prod Res; 2014; 28(16):1280-3. PubMed ID: 24620744
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.
Al-Ani I; Zimmermann S; Reichling J; Wink M
Phytomedicine; 2015 Feb; 22(2):245-55. PubMed ID: 25765829
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
Laudy AE; Kulińska E; Tyski S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
[TBL] [Abstract][Full Text] [Related]
9. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
Misra R; Morrison KD; Cho HJ; Khuu T
J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
[TBL] [Abstract][Full Text] [Related]
10. Synergistic action of indole-3-carbinol with membrane-active agents against multidrug-resistant Gram-negative bacteria.
Wang TP; Yeh TH; Lo CC; Lin KH; Huang MH; Lo HR
Lett Appl Microbiol; 2023 Aug; 76(8):. PubMed ID: 37580156
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interactions in two-drug and three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria including E. coli.
Hamoud R; Zimmermann S; Reichling J; Wink M
Phytomedicine; 2014 Mar; 21(4):443-7. PubMed ID: 24262063
[TBL] [Abstract][Full Text] [Related]
12. Efflux pump inhibitor, phenylalanine-arginine beta-naphthylamide analog potentiates the activity of 5-O-mycaminosyltylonolide for multi-drug resistant Pseudomonas aeruginosa.
Kimishima A; Honsho M; Terai J; Wasuwanich P; Honma S; Matsui H; Hanaki H; Asami Y
J Antibiot (Tokyo); 2024 May; 77(5):331-333. PubMed ID: 38467778
[TBL] [Abstract][Full Text] [Related]
13. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
Sonnet P; Izard D; Mullié C
Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858
[TBL] [Abstract][Full Text] [Related]
15. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
Lamers RP; Cavallari JF; Burrows LL
PLoS One; 2013; 8(3):e60666. PubMed ID: 23544160
[TBL] [Abstract][Full Text] [Related]
16. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
17. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide.
Pannek S; Higgins PG; Steinke P; Jonas D; Akova M; Bohnert JA; Seifert H; Kern WV
J Antimicrob Chemother; 2006 May; 57(5):970-4. PubMed ID: 16531429
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria.
Hamoud R; Reichling J; Wink M
Drug Metab Lett; 2014; 8(2):119-28. PubMed ID: 25692301
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Phenylalanine-arginine-beta-naphthylamide to Ciprofloxacin Minimum Inhibitory Concentration Values and Expression of Efflux Pump System Genes in Acinetobacter baumannii Isolates].
Kaynak Onurdağ F; Kayış U; Ökten S
Mikrobiyol Bul; 2021 Jul; 55(3):285-299. PubMed ID: 34416797
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
Mowla R; Wang Y; Ma S; Venter H
Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
